SCHEMBL20626552

SCHEMBL20626552

COC[C@@H]1CC2C(CC[C@]3(C)C(OC4CCCCO4)CCC23)c2ccc(OC3CCCCO3)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.53
ESR1 P03372 4/20 0.51
ESR2 Q92731 2/20 0.51
CYP19A1 P11511 7/20 0.38
MAPT P10636 4/20 0.35
CYP2C19 P33261 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP2C9 P11712 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP3A4 P08684 3/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TP53 P04637 2/20 0.35
PGR P06401 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
AR P10275 1/20 0.35
PTGS1 P23219 1/20 0.35
PDE4A P27815 1/20 0.35
PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806080 1.00 HSD11B1 (0.53) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL20626554 1.00 HSD11B1 (0.53) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL20626528 1.00 HSD11B1 (0.53) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL6346483 1.00 HSD11B1 (0.53) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL6343325 1.00 HSD11B1 (0.53) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL22925463 0.92 HSD11B1 (0.51) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL14190664 0.91 HSD11B1 (0.56) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL20626551 0.91 HSD11B1 (0.56) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL20626553 0.91 HSD11B1 (0.56) HSD11B1ESR1ESR2CYP19A1MAPT
SCHEMBL806083 0.91 HSD11B1 (0.56) HSD11B1ESR1ESR2CYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723757-B2 6-substituted estradiol derivatives and methods of use ENDECE LLC (US) 2020-07-28 US disclosed
US-20190135853-A1 6-Substituted Estradiol Derivatives and Methods of Use ENDECE LLC 2019-05-09 US disclosed
US-10174070-B2 6-substituted estradiol derivatives and methods of use ENDECE LLC (US) 2019-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10723757-B2 6-substituted estradiol derivatives and methods of use SHBG, HSD17B11, CYP19A1 HSD11B1 55/4885ESR1 5/4885ESR2 4/4885
US-20190135853-A1 6-Substituted Estradiol Derivatives and Methods of Use SHBG, HSD17B11, CYP19A1 HSD11B1 55/4885ESR1 5/4885ESR2 4/4885
US-10174070-B2 6-substituted estradiol derivatives and methods of use NR3C2, SHBG, NR5A1 HSD11B1 46/4885ESR1 17/4885ESR2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.